Press release
United States 7MM Digital Therapeutics for Diabetes Market: FDA Clearance & Clinical Validation Mandate By 2025-2033 | Major Companies - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc.
7MM Digital Therapeutics for Diabetes Market
According to DataM Intelligence Comprehensive Report has released its latest report on the "7MM Digital Therapeutics for Diabetes Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/7mm-digital-therapeutics-for-diabetes-market?ca
Latest M & A:
The diabetes segment held a dominant market share in digital therapeutics, driven by the rising global prevalence of diabetes, with solutions like mobile apps, wearables, and real-time glucose monitoring improving disease management and patient adherence.
Major companies actively developing and marketing digital therapeutics for diabetes include Welldoc, Omada Health, Livongo, and Dexcom, with a focus on integrated, AI-powered, and personalized care solutions.
The Asian-Pacific region, particularly India and China, is witnessing rapid growth in digital health, with market sizes in India estimated at USD 219.41 million in 2025, expected to grow at a CAGR of 6.78%, driven by smartphone penetration and government initiatives.
Increasing adoption of remote monitoring, telemedicine, and AI-based analytics for diabetes management are key factors propelling market growth.
The primary drivers include rising diabetes prevalence, advancements in digital health technologies, and demand for cost-effective, scalable care models.
Challenges include data privacy concerns, lack of reimbursement policies in certain regions, and digital literacy barriers among older populations.
Regulatory approvals and clinical validation studies have further accelerated the uptake of digital therapeutics in diabetes management globally.
Industry Developments:
USA:
Major innovations include AI-enabled apps integrating with continuous glucose monitors (CGMs) and smart insulin pens to provide real-time personalized treatment guidance, enhancing compliance and health outcomes.
Companies like Welldoc (BlueStar) and Omada Health are leading with platforms that offer integrated diabetes management solutions incorporating behavioral coaching and data analytics.
Market growth is supported by increased smartphone penetration, telehealth adoption, and strong investments in digital health technologies.
Data privacy and security concerns remain key challenges affecting adoption and regulatory compliance.
Japan:
Japan is witnessing steady adoption of digital therapeutics for diabetes, driven by government support for digital health and increasing smartphone use.
Innovations focus on integrating digital therapeutics with existing healthcare systems to support personalized diabetes management, leveraging real-time glucose monitoring and AI-driven coaching.
The market growth aligns with Japan's broader healthcare digitization initiatives and commitment to improving chronic disease outcomes.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/7mm-digital-therapeutics-for-diabetes-market?ca
Major Key Player:
7MM digital therapeutics for diabetes market include Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH, Dexcom, Inc., Health2Sync, iHealth Labs Inc. and Medtronic plc
Key Segments:
➥ By Product Type: Software Solutions, Hardware Solutions
➥ By Application: Type-1 Diabetes, Type-2 Diabetes, Pre-Diabetes
➥ By End-User: Hospitals, Specialty Clinics, Homecare Settings, Others
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=7mm-digital-therapeutics-for-diabetes-market?ca
Product Launches
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/7mm-digital-therapeutics-for-diabetes-market?ca
Latest News
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?ca
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States 7MM Digital Therapeutics for Diabetes Market: FDA Clearance & Clinical Validation Mandate By 2025-2033 | Major Companies - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc. here
News-ID: 4280092 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Toxoid Vaccine Market Demand & Supply Dynamics | Access Detailed M …
global toxoid vaccine market reached US$ 5,634.84 Million in 2024 and is expected to reach US$ 8,850.18 Million by 2033, growing at a CAGR of 5.8 % during the forecast period of 2025-2033.
United States Toxoid Vaccine Market size in 2024: USD 2.1 B and projection to USD 3.3 B by 2032 with a CAGR 5.8% (2025-2032)
Japan Toxoid Vaccine Market size in 2024: USD 0.46 B and projection to USD 0.62…
France Hydrogen Fuel Cell Market to Hit $435.61 Million by 2032, Driven by Decar …
Leander, Texas, United States - Nov.20.2025
As per DataM intelligence research report" France Hydrogen Fuel Cell Market reached US$58.60 million in 2024 and is expected to reach US$435.61 million by 2032, growing with a CAGR of 28.50% during the forecast period 2025-2032.". France's push toward green mobility is accelerating hydrogen fuel cell development for transportation and industry.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/france-hydrogen-fuel-cell-market?sp
Cambodia: Recent Renewable Energy…
Global Human Milk Oligosaccharides Market Set to Accelerate Growth to USD 850.5 …
Leander, Texas - The Global Human Milk Oligosaccharides (HMO) Market was valued at USD 196.5 million in 2022 and is expected to reach USD 850.5 million by 2030, growing at an impressive CAGR of 20.1% during 2024-2031.
Market growth is fueled by rising demand for premium infant nutrition products, increasing awareness of the health benefits of HMOs, and advancements in biotechnology enabling large-scale, cost-effective production. Expanding applications in dietary supplements and…
Cambodia Renewable Energy Certificate Market to Reach $7.01 Million by 2032, Dri …
Leander, Texas, United States - Nov.20.2025
As per DataM intelligence research report"The Cambodia renewable energy certificate Market reached US$ 5.62 million in 2024 and is expected to reach US$ 7.01 million by 2032, growing with a CAGR of 2.6% during the forecast period 2025-2032.". Government incentives and renewable energy initiatives are promoting adoption of energy certificates in Cambodia.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/cambodia-renewable-energy-certificate-market?sp
Cambodia: Recent Renewable…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
